i'm on a glp-1 Jennifer Manne-Goehler, MD, ScD, explains why medications shouldn't be used as "quick fix" and outlines what to consider before taking them GLP-1 Receptor Agonists: Mascots &

Semaglutide GLP-1 is intended for long-term use to facilitate meaningful and sustainable weight loss

Understanding that Semaglutide acts directly on the liver's internal architecture, independent of weight loss, is a massive shift for metabolic therapy

Type 3 diabetes and its role implications in alzheimers disease

Claims for GLP-1s Increased Four-Fold Between 2019 and 2024 In accordance with an increase in both the number of Medicare Part D enrollees using GLP-1s and spending on these products, the number of claims for GLP-1s increased four-fold between 2019 and 2024, from 4.8 million to 21.8 million, with claims doubling between 2022 and 2024 alone

By staying informed about the latest news and working with qualified healthcare professionals, patients can make the best decisions for their health and well-being

Can the device supply keep up with the demand